These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36017915)

  • 1. A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.
    Xu X; Zhang Y; Wang M; Zhang X; Jiang W; Wu S; Ti X
    Crit Rev Eukaryot Gene Expr; 2022; 32(8):43-53. PubMed ID: 36017915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
    Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
    Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
    Zhang C; Huang J; Lou K; Ouyang H
    Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway.
    Zhang L; He X; Jin T; Gang L; Jin Z
    Biomed Pharmacother; 2017 Dec; 96():884-891. PubMed ID: 29145165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
    Guo J; Chen Z; Jiang H; Yu Z; Peng J; Xie J; Li Z; Wu W; Cheng Z; Xiao K
    Cancer Cell Int; 2019; 19():312. PubMed ID: 31787849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA DLX6-AS1 is upregulated in preeclampsia and modulates migration and invasion of trophoblasts through the miR-376c/GADD45A axis.
    Tan Y; Xiao D; Xu Y; Wang C
    Exp Cell Res; 2018 Sep; 370(2):718-724. PubMed ID: 30055134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β-catenin signaling pathway.
    Lin H; Shangguan Z; Zhu M; Bao L; Zhang Q; Pan S
    J Cell Biochem; 2019 Jun; 120(6):10625-10632. PubMed ID: 30697812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
    Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
    Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
    Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short peptide encoded by long non-coding RNA RNF217-AS1 inhibits stomach cancer tumorigenesis, macrophage recruitment, and pro-inflammatory responses.
    Ma Q; Ma F; Zhang B; Zhang Y; Peng L; Li X
    Amino Acids; 2024 Jul; 56(1):45. PubMed ID: 39007996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis.
    Zhang Y; Yuan J; Guo M; Xiang R; Xie T; Zhuang X; Dai W; Li Q; Lai Q
    Biol Direct; 2023 Feb; 18(1):3. PubMed ID: 36747258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.
    Cheng Y
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Antisense Long Noncoding RNA HHIP-AS1 Suppresses Non-Small-Cell Lung Cancer Progression by Increasing HHIP Stability via Interaction with CELF2.
    Yang Y; Cheng Y; Mou Y; Tang X; Mu X
    Crit Rev Eukaryot Gene Expr; 2022; 33(1):67-77. PubMed ID: 36374812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.